There is a current case in Kansas where a murder defendant has been ordered to take anti-psychotic medication to render him competent to stand trial. The news story implies that this is the first case to apply the recent Supreme Court decision about involuntary medication.
I went to find the case, Sell v. United States. I wanted to see what conditions the Court placed on ordering involuntary medication. It left me with some questions that I don’t have the legal background to understand, and I was hoping for some help here.
1: Is the Kansas case actually an application of Sell? That defendant, Marc Sappington, is accused of a violent crime (murder). Although Sell was also accused of attempted murder, the proceedings that lead to the Supreme Court decision concentrated on the Medicaid fraud charges. I am not sure how that happened (reasoning for which would be also appreciated), but the first part of the decision clearly states that the question concerns nonviolent crimes.
2: The standards seem very fuzzy; are the criteria clear to most courts? I ask this because criteria such as “important government interests are at stake” and “involuntary medication will significantly further those concomitant state interests” must have a more precise meaning than I am aware of in order to be usable. Put another way: the other two criteria of medical necessity and medical appropriateness are clearer to me, but only because I know some of the “back story” behind those terms. To me, “important government interests” is especially vague, and could be stretched to ludicrous lengths.
2A: Semi-related observation: I found it amusing that the Court got itself caught in the crossfire of the psychology-psychiatry wars. The American Psychological Association and American Psychiatric Association filed competing briefs on effectiveness of drug and non-drug therapies in treating psychoses. I’ll leave as an exercise for the reader to decide where each brief came down 
3: Did this opinion create a new “collateral order” exemption? Is that a significant thing? Scalia’s dissent seems to imply that it does and it is very significant. I am aware of his general views on common law and “judicial activism”. In this case, however, wouldn’t the practical effect of his proposed resolution (remand with instruction to dismiss) be to force Sell to take the medication? For those who may not know, anti-psychotics have high side-effect profiles. Some of these side effects are major, and some can be permanent, even after the medication is withdrawn. From the Merck Manual
One of my wife’s relatives has this tardive dyskinesia, which is extremely distracting when talking to him, and the medicine that caused it was changed long ago. I would think that this side effect, not to mention the sedation, tremors and death, could definitely have an effect at trial. Is it that Scalia’s dissent does not understand that risk or does not care that it is there? Or am I understanding the practical effect incorrectly?
Thanks in advance. I know I bring a lot of these questions to the Legal Doper community, and I appreciate your collective willingness to help.
